Scarica l'app Stockscreener
63.75
1.02%
-0.66
Dopo l'orario di chiusura:
63.91
0.16
+0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BMY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$64.41
Aprire:
$64.92
Volume 24 ore:
6.50M
Relative Volume:
0.59
Capitalizzazione di mercato:
$130.22B
Reddito:
$48.48B
Utile/perdita netta:
$7.27B
Rapporto P/E:
17.89
EPS:
3.5626
Flusso di cassa netto:
$11.91B
1 W Prestazione:
-6.37%
1M Prestazione:
-1.68%
6M Prestazione:
+6.02%
1 anno Prestazione:
+35.21%
Intervallo 1D:
$63.73
$64.92
Intervallo di 1 settimana:
$63.73
$67.72
Portata 52W:
$42.52
$68.64
Bristol Myers Squibb Co Stock (BMY) Company Profile
Nome
Bristol Myers Squibb Co
Settore
Industria
Telefono
(609) 252-4621
Indirizzo
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NY
Compare BMY vs LLY, JNJ, ABBV, MRK, NVS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BMY
Bristol Myers Squibb Co
|
63.75 | 131.57B | 48.48B | 7.27B | 11.91B | 3.5626 |
LLY
Lilly Eli Co
|
1,123.00 | 1.00T | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
266.35 | 643.64B | 97.93B | 21.04B | 17.80B | 8.6278 |
ABBV
Abbvie Inc
|
255.00 | 443.39B | 62.82B | 3.60B | 19.98B | 2.0274 |
MRK
Merck Co Inc
|
144.71 | 363.98B | 65.51B | 8.93B | 14.12B | 3.5532 |
NVS
Novartis Ag Adr
|
137.48 | 261.31B | 54.66B | 13.58B | 16.05B | 7.0171 |
Bristol Myers Squibb Co Stock (BMY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-25 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2026-02-20 | Iniziato | Barclays | Overweight |
| 2026-01-07 | Aggiornamento | UBS | Neutral → Buy |
| 2025-12-15 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-12-12 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2025-11-13 | Iniziato | Scotiabank | Sector Perform |
| 2025-08-05 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-04-22 | Iniziato | Cantor Fitzgerald | Neutral |
| 2025-04-22 | Iniziato | Piper Sandler | Overweight |
| 2024-12-16 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-12-10 | Ripresa | BofA Securities | Neutral |
| 2024-11-15 | Iniziato | Wolfe Research | Peer Perform |
| 2024-11-13 | Aggiornamento | Daiwa Securities | Neutral → Outperform |
| 2024-11-12 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2024-10-25 | Downgrade | Citigroup | Buy → Neutral |
| 2024-10-17 | Iniziato | Bernstein | Mkt Perform |
| 2024-07-29 | Downgrade | Barclays | Overweight → Equal Weight |
| 2024-03-11 | Downgrade | Societe Generale | Buy → Hold |
| 2024-02-06 | Downgrade | Redburn Atlantic | Buy → Neutral |
| 2024-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-11-15 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2023-11-09 | Iniziato | Deutsche Bank | Hold |
| 2023-11-02 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2023-10-27 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2023-10-27 | Aggiornamento | HSBC Securities | Reduce → Hold |
| 2023-10-27 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-10-20 | Ripresa | UBS | Neutral |
| 2023-07-14 | Iniziato | HSBC Securities | Reduce |
| 2023-07-10 | Iniziato | SVB Securities | Market Perform |
| 2023-06-28 | Iniziato | Daiwa Securities | Outperform |
| 2023-03-06 | Iniziato | Jefferies | Hold |
| 2023-01-17 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-11-18 | Iniziato | Credit Suisse | Neutral |
| 2022-10-10 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-09-14 | Downgrade | Berenberg | Buy → Hold |
| 2022-06-03 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-04-06 | Ripresa | Morgan Stanley | Underweight |
| 2021-12-17 | Iniziato | Goldman | Buy |
| 2021-12-09 | Ripresa | Wells Fargo | Equal Weight |
| 2021-11-19 | Iniziato | BMO Capital Markets | Outperform |
| 2021-11-01 | Downgrade | Argus | Buy → Hold |
| 2021-07-27 | Ripresa | Truist | Buy |
| 2021-04-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-13 | Aggiornamento | Truist | Hold → Buy |
| 2020-11-16 | Aggiornamento | Societe Generale | Hold → Buy |
| 2020-11-10 | Ripresa | Bernstein | Mkt Perform |
| 2020-11-06 | Downgrade | Gabelli & Co | Buy → Hold |
| 2020-10-19 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-29 | Iniziato | Berenberg | Buy |
| 2020-07-28 | Iniziato | Raymond James | Outperform |
| 2020-04-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-03-23 | Downgrade | Societe Generale | Buy → Hold |
| 2020-02-27 | Iniziato | Barclays | Equal Weight |
| 2020-01-06 | Ripresa | Citigroup | Buy |
| 2019-12-13 | Aggiornamento | Argus | Hold → Buy |
| 2019-11-22 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-10-17 | Ripresa | BofA/Merrill | Buy |
| 2019-08-14 | Aggiornamento | Atlantic Equities | Neutral → Overweight |
| 2019-05-28 | Iniziato | Goldman | Buy |
| 2019-05-20 | Downgrade | Argus | Buy → Hold |
| 2019-05-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2019-05-03 | Ripresa | JP Morgan | Overweight |
| 2019-01-15 | Aggiornamento | Societe Generale | Sell → Buy |
| 2018-10-22 | Downgrade | Citigroup | Buy → Neutral |
Mostra tutto
Bristol Myers Squibb Co Borsa (BMY) Ultime notizie
Bristol-Myers Squibb Co (BMY) Insider Sale: EVP, Chief Medical O - GuruFocus
BMY Gains 19.4% Year to Date: Should You Buy, Sell or Hold the Stock? - TradingView
Core Capital Management & Research inc. Invests $4.73 Million in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Passes the Dividend Screen, but Payout Sustainability Is the Key Question - ChartMill
Allworth Financial LP Sells 91,375 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb stock heads into the open after a 3.2 percent drop - ad-hoc-news.de
Bristol-Myers Squibb stock heads into the open after a 3.2 percent drop - ad-hoc-news.de
Will The Recent Pipeline Progress Boost BMY's Portfolio Expansion? - Zacks Investment Research
What macro factors could move Bristol Myers Squibb (NYSE:BMY) shares this week? - Kalkine Media
National Coalition of Pharmaceutical Industry, Academic, and Nonprofit Partners Launches Fifth Winn CIPP Cohort - Finviz
Bristol Myers Squibb Company $BMY Shares Purchased by Waverly Advisors LLC - MarketBeat
CD&R Taps Former Bristol-Myers CEO Caforio in Healthcare Push - Bloomberg.com
Bristol Myers (NYSE: BMY) insider unloads 6,249 shares - Stock Titan
Bristol-Myers Squibb stock heads into the open after a 3.2% drop - ad-hoc-news.de
Bristol-Myers Squibb Co (BMY) Shares Fall 3.2% -- What GF Score of 71 Tells Investors - GuruFocus
Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Bristol-Myers Squibb Co Stock (BMY) Moved Down by 3.25% on Sep 8: Facts Behind the Movement - TradingKey
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial | Business Information & News | FE - Westlaw Today
What's Going On With Bristol Myers Stock Today?Bristol-Myers Squibb (NYSE:BMY) - Benzinga
Bristol Myers Squibb stock gains on positive arlocabtagene autoleucel trial results - AD HOC NEWS
Roivant surges on ‘exceptional’ results; Bristol Myers touts first-of-its-kind CAR-T therapy - Yahoo Finance
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial - Reuters
Bristol Myers' blood cancer cell therapy meets main goal in mid-stage trial - yahoo.com
Why Is Bristol Myers Squibb (NYSE:BMY) Under NYSE Focus Today? - Kalkine Media
Bristol Myers Squibb Company $BMY Shares Acquired by Amundi - MarketBeat
Bristol Myers Squibb stock heads into the open after a 1.9% slide - ad-hoc-news.de
Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2% - GlobeNewswire Inc.
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $99.23 Million Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol-Myers Squibb (BMY): Investor Outlook with a Focus on Dividend Yield and Strategic Collaborations - DirectorsTalk Interviews
TD Waterhouse Canada Inc. Buys 53,881 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Why Davy thinks Bristol-Myers Squibb’s latest rally is one to cash in on - Business Post
Saudi Central Bank Purchases 67,780 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Sold by Mid American Wealth Advisory Group Inc. - MarketBeat
Bristol-Myers Squibb (NYSE:BMY) Flashes Strong Technical Breakout Setup - ChartMill
Munich Reinsurance Co Stock Corp in Munich Raises Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Bristol Myers Squibb Company $BMY Shares Purchased by NEOS Investment Management LLC - MarketBeat
Bristol Myers Squibb Company $BMY Position Boosted by Concurrent Investment Advisors LLC - MarketBeat
Atopic Dermatitis Drugs Market Set to Reach USD 33.42 Billion by 2035, at a CAGR of 7.70% - GlobeNewswire Inc.
Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today - Yahoo Finance
Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch
Will Long‑Term Camzyos Data and Real‑World Evidence Change Bristol Myers Squibb's (BMY) Narrative? - simplywall.st
Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook? - TradingView
Bristol-Myers Squibb stock steadies as CAR-T trial pause meets strong Q2 2026 figures - AD HOC NEWS
A Wall Street Analyst Spotted the Trial Freeze—Then Came News of Three Deaths - Benzinga
Bristol Myers Squibb: Still Cheap, Despite What The Chart Says (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb: Buy The Growth Portfolio At A Value Price (NYSE:BMY) - Seeking Alpha
Bristol Myers Squibb Company $BMY Shares Bought by Burford Brothers Inc. - MarketBeat
Bristol Myers Squibb stock gains on Q2 beat and raised 2026 guidance - AD HOC NEWS
Bristol-Myers Squibb Stock: Is BMY Outperforming the Healthcare Sector? - Barchart.com
Revisiting Stock Picks Dexcom, Bristol Myers Squibb, Quanta Services - Barron's
Bristol Myers Squibb stock gains on CAR-T pause and Camzyos momentum - AD HOC NEWS
Bristol Myers Squibb Co Azioni (BMY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.47%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):